Personal Capital Advisors Corp Eli Lilly & CO Transaction History

Personal Capital Advisors Corp

$20.6 Billion
Q4 2022

A detailed history of Personal Capital Advisors Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Personal Capital Advisors Corp holds 48,691 shares of LLY stock, worth $43.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

48,691

Previous 49,541 1.72%

Holding current value

$43.7 Million

Previous $16 Million 11.2%

% of portfolio

0.09%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $273,317 - $318,469	-850 Reduced 1.72%	48,691 $17.8 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $56,627 - $64,533	191 Added 0.39%	49,541 $16 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $410,569 - $482,068	-1,473 Reduced 2.9%	49,350 $16 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $319,882 - $397,532	1,363 Added 2.76%	50,823 $14.6 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $608,219 - $754,803	2,705 Added 5.79%	49,460 $13.6 Million

Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $272,568 - $335,433	1,230 Added 2.7%	46,755 $10.8 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $1.01 Million - $1.31 Million	5,604 Added 14.04%	45,525 $10.4 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $878,619 - $1.14 Million	5,347 Added 15.47%	39,921 $7.46 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $711,789 - $941,869	5,456 Added 18.74%	34,574 $5.84 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $405,321 - $468,828	2,772 Added 10.52%	29,118 $4.31 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $1.21 Million - $1.45 Million	-8,846 Reduced 25.14%	26,346 $4.33 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $174,408 - $215,867	1,465 Added 4.34%	35,192 $4.9 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $620,991 - $769,153	5,808 Added 20.8%	33,727 $4.43 Million
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $446,809 - $486,013	4,184 Added 17.63%	27,919 $3.12 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $439,282 - $512,753	3,965 Added 20.06%	23,735 $2.63 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $236,867 - $278,810	2,128 Added 12.06%	19,770 $2.57 Million
Q4 2018 Jan 16, 2019	BUY	$105.9 - $118.64 $461,512 - $517,033	4,358 Added 32.81%	17,642 $2.04 Million
Q3 2018 Oct 09, 2018	BUY	$85.86 - $107.31 $276,297 - $345,323	3,218 Added 31.97%	13,284 $1.43 Million
Q2 2018 Aug 01, 2018	BUY	$75.7 - $86.88 $342,921 - $393,566	4,530 Added 81.83%	10,066 $859,000
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $178,549 - $210,765	2,406 Added 76.87%	5,536 $428,000
Q4 2017 Jan 19, 2018	BUY	$81.94 - $87.89 $256,472 - $275,095	3,130	3,130 $264,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.

Account

Personal Capital Advisors Corp Eli Lilly & CO Transaction History